Genomic epidemiology of global Klebsiella pneumoniae carbapenemase (KPC)-producing Escherichia coli by Stoesser, N et al.
1Scientific RepoRts | 7: 5917  | DOI:10.1038/s41598-017-06256-2
www.nature.com/scientificreports
Genomic epidemiology of 
global Klebsiella pneumoniae 
carbapenemase (KPC)-producing 
Escherichia coli
N. Stoesser  1, A. E. Sheppard1, G. Peirano2,3, L. W. Anson1, L. Pankhurst1, R. Sebra4, H. T. T. 
Phan1,5, A. Kasarskis4, A. J. Mathers6,7, T. E. A. Peto1, P. Bradford8, M. R. Motyl9, A. S. Walker1, 
D. W. Crook1 & J. D. Pitout2,3,10,11,12
The dissemination of carbapenem resistance in Escherichia coli has major implications for the 
management of common infections. blaKPC, encoding a transmissible carbapenemase (KPC), has 
historically largely been associated with Klebsiella pneumoniae, a predominant plasmid (pKpQIL), and 
a specific transposable element (Tn4401, ~10 kb). Here we characterize the genetic features of blaKPC 
emergence in global E. coli, 2008–2013, using both long- and short-read whole-genome sequencing. 
Amongst 43/45 successfully sequenced blaKPC-E. coli strains, we identified substantial strain diversity 
(n = 21 sequence types, 18% of annotated genes in the core genome); substantial plasmid diversity (≥9 
replicon types); and substantial blaKPC-associated, mobile genetic element (MGE) diversity (50% not 
within complete Tn4401 elements). We also found evidence of inter-species, regional and international 
plasmid spread. In several cases blaKPC was found on high copy number, small Col-like plasmids, 
previously associated with horizontal transmission of resistance genes in the absence of antimicrobial 
selection pressures. E. coli is a common human pathogen, but also a commensal in multiple 
environmental and animal reservoirs, and easily transmissible. The association of blaKPC with a range of 
MGEs previously linked to the successful spread of widely endemic resistance mechanisms (e.g. blaTEM, 
blaCTX-M) suggests that it may become similarly prevalent.
Carbapenemases have emerged over the last 15 years as a major antimicrobial resistance threat in 
Enterobacteriaceae, many species of which are major human pathogens1. They are enzymes with broad-spectrum 
hydrolytic activity targeting beta-lactams, and commonly associated with additional resistance mechanisms pro-
ducing cross-resistance to other antimicrobial classes2. The Klebsiella pneumoniae carbapenemase (KPC) enzyme, 
encoded by alleles of the blaKPC gene, represents one of the five major carbapenemase families, others being the 
VIM, IMP and NDM metallo-beta-lactamases, and the OXA-48-like oxacillinases3.
KPC, unlike the other major carbapenemases, is an Ambler class A enzyme, with a serine in the active site, 
which hydrolyses penicillins, cephalosporins, aztreonam and carbapenems4. At least 18 variants are known, with 
nucleotide mutations across 20 positions (13 amino acid substitutions), and one variant with a 6 bp deletion 
1Modernising Medical Microbiology Consortium, Nuffield Department of Medicine, John Radcliffe Hospital, 
University of Oxford, Oxford, United Kingdom. 2Division of Microbiology, Calgary Laboratory Services, Calgary, 
Alberta, Canada. 3Department of Pathology and Laboratory Medicine, University of Calgary, Alberta, Canada. 4Icahn 
Institute and Department of Genetics and Genomic Sciences, Icahn School of Medicine, Mount Sinai, New York, 
USA. 5National Institute for Health Research (NIHR) Health Protection Research Unit (NIHR HPRU) in Healthcare 
Associated Infections and Antimicrobial Resistance, University of Oxford, Oxford, United Kingdom. 6Division 
of Infectious Diseases and International Health, Department of Medicine, University of Virginia Health System, 
Charlottesville, Virginia, USA. 7Office of Hospital Epidemiology, University of Virginia Health System, Charlottesville, 
Virginia, USA. 8AstraZeneca Pharmaceuticals LP, Waltham, Massachusetts, USA. 9Clinical Microbiology, Merck and 
Co Inc., Rahway, New Jersey, USA. 10Department of Microbiology, Immunology and Infectious diseases, University 
of Calgary, Alberta, Canada. 11Snyder Institute for Chronic diseases, University of Calgary, Alberta, Canada. 
12Department of Medical Microbiology, University of Pretoria, Pretoria, South Africa. Correspondence and requests 
for materials should be addressed to N.S. (email: nicole.stoesser@ndm.ox.ac.uk)
Received: 19 January 2017
Accepted: 12 June 2017
Published: xx xx xxxx
OPEN
www.nature.com/scientificreports/
2Scientific RepoRts | 7: 5917  | DOI:10.1038/s41598-017-06256-2
(KPC-14, nucleotide positions: 722–727]. blaKPC is typically located within a 10 kb mobile transposon (Tn4401), 
most often on conjugative plasmids. In publicly available sequence data, blaKPC is mostly found as a single 
copy on any individual plasmid although it can exist in duplicate (6/133 [5%] KPC plasmid structures with 
Tn4401/blaKPC-2/3 duplications available in GenBank, March 2017 [Phan HTT, unpublished data]). It has also 
been described on multiple plasmids within the same isolate, and/or in multiple copies shared amongst the chro-
mosome and plasmids5, 6.
The first KPC-producer, a K. pneumoniae strain harbouring blaKPC-2, was identified in 1996 in the eastern 
USA; since then, KPC-2 and KPC-3 (H272Y [C814T] with respect to KPC-2) have become widespread, and 
entrenched in endemic hotspots in the USA, Greece, Israel, China and Latin America7, 8. KPC-3 confers a 4-fold 
increase in ceftazidime resistance compared with KPC-29. The other variants remain relatively rare in published 
surveys. The spread of the epidemic K. pneumoniae lineage, ST258, is thought to have contributed significantly 
to global blaKPC-2/blaKPC-3 dissemination10, although these genes have now been observed in several species of 
Enterobacteriaceae5, 6.
Acquired carbapenem resistance in Escherichia coli was considered rare as recently as 2010, although the first 
cases of KPC-E. coli were observed as early as 2004–2005 in Cleveland (n = 1, KPC-211), New York City (n = 2, 
KPC-2), New Jersey, USA (n = 1, KPC-3)12, and Tel Aviv, Israel (n = 4, KPC-2)13, 14. No apparent epidemiological 
links between any of these cases were identified. Genotyping was limited at this time, but supported diversity 
being present in both host E. coli and blaKPC plasmid backgrounds. Since then, direct, plasmid-mediated transfer 
of blaKPC into E. coli within human hosts has been described15, and clusters of KPC-E. coli have been identified 
in several locations, from China to Puerto Rico16, 17, and in the context of clinical infections16, 17, asymptomatic 
colonization18 and the environment19.
More recently there has been concern around blaKPC in E. coli sequence type (ST) 131, a globally dissemi-
nated, clinically successful strain20–22. Notably, the H30R/C1 (fluoroquinolone-resistant) and H30Rx/C2 (fluo-
roquinolone and extended-spectrum cephalosporin-resistant) ST131 sub-lineages have previously emerged in 
association with particular drug resistance mechanisms, including the extended-spectrum beta-lactamase (ESBL) 
gene, blaCTX-M-15 (clade C2)23, 24. Given the high rates of ST131 community and healthcare-associated infections25, 
and its capacity for asymptomatic gastrointestinal colonisation26, a stable association of ST131 with blaKPC could 
have important consequences for the management of E. coli infections14.
Despite these concerns, there are limited detailed molecular epidemiological data investigating the genetic 
structures associated with blaKPC in E. coli and the extent to which these may have been shared amongst 
Enterobacteriaceae. Here we used short-read (Illumina) and long-read (PacBio) sequencing to investigate 43 
blaKPC-positive E. coli isolates obtained consecutively from global surveillance schemes (67 participating coun-
tries, 2008–2013), fully resolving the blaKPC-containing plasmids in 22 cases, and comparing these data with other 
blaKPC plasmid sequences.
Results
Global blaKPC-E. coli strains are diverse, even within the most prevalent ST, ST131, with evi-
dence for local transmission. 45 isolates were obtained from 21 cities in 11 countries across four conti-
nents (2010–2013; previous laboratory typing results summarized in Table S1). One isolate was blaKPC-negative on 
whole-genome sequencing (WGS; ecol_252), potentially having lost blaKPC during storage or sub-culture in the 
intervening time period between when the original typing was undertaken and the subsequent DNA extraction 
and preparation for WGS. For one isolate the WGS data were inconsistent with the lab typing results (ecol_451), 
likely representing a laboratory mix-up; ecol_252 and ecol_451 were therefore excluded from subsequent anal-
yses. The other 43 isolates were successfully sequenced (for quality metrics see Table S1). Amongst these 43 iso-
lates, twenty-one different E. coli STs were represented (Table 1; predicted in silico from WGS), including: ST131 
[n = 16], ST410 [n = 4], ST38 [n = 3], ST10, ST69 [n = 2 each] (remaining isolates singleton STs).
Of 16,053 annotated open reading frames (ORFs) identified across all KPC-E. coli isolates, only 2,950 (18.4%) 
were shared in all isolates (“core”), and a further 222 (1.4%) in 95- < 100% of isolates (“soft core”27). At the nucleo-
tide level there were 213,352 single nucleotide variants (SNVs) in the core genome, consistent with the previously 
observed species diversity28. Resistance gene profiles also varied markedly between strains, with some harbouring 
several beta-lactam, aminoglycoside, tetracycline and fluoroquinolone resistance mechanisms (e.g. ecol_224) and 
others containing blaKPC only (e.g. ecol_584; Fig. 1). For the 16 KPC-ST131 strains, 4,071/7,910 (51%) ORFs were 
core, with 6,778 SNVs across the core genome of these isolates, again consistent with previous global studies of 
ST131 diversity23, 24 (Figure S1). Accessory genomes were highly concordant for some (e.g. ecol_356/ecol_276/
ecol_875), but not all (e.g. ecol_AZ159/ecol_244) isolates that were closely related in their core genomes, sup-
porting highly variable evolutionary dynamics between core and accessory genomes (Fig. 1). The geographic 
distribution of isolates closely related in both the core and accessory genomes supports local (e.g. ecol_AZ166, 
ecol_AZ167 [ST131, Beijing, China]) transmission of particular KPC-E. coli strains. The homology of genetic 
flanking motifs around the blaKPC genes in these closely related isolate pairs would also be consistent with this 
hypothesis, and less consistent with multiple acquisition events of blaKPC within the same genetic background, 
especially given the diversity in blaKPC flanking sequences observed across the rest of the dataset (see below).
blaKPC genes appear restricted to plasmid contexts in E. coli at present, but may exist in mul-
tiple copies on single plasmid structures or in high copy number plasmids. Thirty-four isolates 
(80%) contained blaKPC-2, and nine isolates (20%) blaKPC-3. Chromosomal integration of blaKPC has been described 
in other Enterobacteriaceae, Pseudomonas and Acinetobacter spp. but remains rare5, 29, 30. There was no evidence 
of chromosomal integration of blaKPC in either the 18 chromosomal structures reconstructed from long-read 
sequencing, or based on review of the annotations in the blaKPC-containing contigs (derived from Illumina de 
novo assemblies) for the other 25 isolates. blaKPC alleles were not segregated by ST.
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Estimates of blaKPC copy number per bacterial chromosome varied between <1 (ecol_879, ecol_881) and 
55 (ecol_AZ152). In nine cases this estimate was ≥10 copies of blaKPC per bacterial chromosome (ecol_276, 
ecol_356, ecol_867, ecol_869, ecol_870, ecol_875, ecol_AZ150, ecol_AZ152, ecol_AZ159, Table S2). Six of these 
isolates contained blaKPC in a col-like plasmid context, in two cases the plasmid rep type was unknown, and in 
one case it was an IncN replicon. Plasmid copy number is associated with higher levels of antibiotic resistance 
if the relevant gene is located on a high-copy unit. Interestingly, high copy number plasmids are postulated to 
have higher chances of fixing in descendant cells, as they distribute more adequately by chance and without 
the requirement for partitioning systems31, and of being transferred in any conjugation event, either directly or 
indirectly32–34.
blaKPC and non-blaKPC plasmid populations across global KPC-E. coli strains are extremely 
diverse. Plasmid Inc typing revealed the presence of a median of four plasmid replicon types per isolate 
(range: 1–6; IQR: 3–5), representing wide diversity (Table 1). However, IncN, col, IncFIA and IncI1 replicons were 
disproportionately over-represented in certain STs (p < 0.05; Table 1). Amongst the 18 isolates that underwent 
PacBio sequencing, we identified 53 closed, non-blaKPC plasmids, ranging from 1,459 bp to 289,903 bp (Table S1; 
at least four additional, partially complete plasmid structures were present). Of these non-blaKPC plasmids, 10 
(size: 2,571–150,994 bp) had <70% similarity (defined by percent sequence identity multiplied by proportion of 
query length demonstrating homology) to other sequences available in GenBank, highlighting that a proportion 
of the “plasmidome” in KPC-E. coli remains incompletely characterized. For the other 43 plasmids, the top match 
in GenBank was a plasmid from E. coli in 35 cases, K. pneumoniae in 5 cases, and Citrobacter freundii, Shigella 
sonnei, Salmonella enterica in 1 case each (Table S3).
Twenty-two blaKPC plasmid structures were fully resolved (17 from Pacbio data only, four from Illumina data 
only, 1 from both PacBio and Illumina data), ranging from 14,029 bp to 287,067 bp (median = 55,590 bp; IQR: 
23,499–82,765 bp). These blaKPC-containing plasmids, and six additional cases where blaKPC was identified on a 
replicon-containing contig, were highly diverse based on Inc typing (Table S1). IncN was the most common type 
(n = 8/28 type-able blaKPC structures; 29%), followed by small, col-like plasmids (n = 6/28 [col-like plasmids with 
single replicons only]; 21%). Other less common types were: A/C2, FII(k), U (all n = 2); and L/M, P, Q1 and R 
Inc type
Sequence type (number of isolates) Total number 
of isolates 
[number 
of blaKPC 
plasmids] p10 (n=2)
38 
(3)
44 
(1)
69 
(2)
101 
(1)
131 
(16)
155 
(1)
167 
(1)
182 
(1)
224 
(1)
297 
(1)
354 
(1)
361 
(1)
393 
(1)
410 
(4)
428 
(1)
540 
(1)
648 
(1)
744 
(1)
1193 
(1)
1431 
(1)
A/C2 1 1[1] 1 1[1] 4[2] 0.05
B/O/K/Z 1 1[0] 1
FIA 1 1 1 1 15 1 1 1 2 1 1 26[0] 0.001
FIB 2 1 2 1 11 1 1 1 1 4 1 1 1 1 29[0] 0.14
FII 1 2 1 1 1 12[2]a,b 1 1 1 4[2] 1 1[1]c 1 1 1 30[5]a,b,c 0.34
FIC(FII) 1 1 2[0] 0.67
HI1b 1 1[0] 0.47
HI2+HIA2 1 1[0] 1
I1 1 2 1 1 2 1 8[0] 0.02
I2 1 1[0] 0.67
L/M 1[1] 1 2[1] 0.26
N 1[1] 1 1[1] 3[3] 1 1 1 4[2] 1[1] 1 1 16[8] 0.009
P 1[1] 1 2 4[1] 0.47
Q1 1 2[1] 1 1 1 6[1] 0.31
R 2[1] 2[1] 1
U 1[1] 1[1] 2[2] 0.21
X1 1 1 0.37
X3 3 3[0] 1
X4 4 3[0] 0.98
Y 1 1[0] 0.37
col 1 1 1 1 12[5]d 1[1] 1[1] 4 1 1 24[7]d 0.04
p0111 1 0.37
Table 1. Plasmid replicon families present by ST, using the PlasmidFinder database58. Undmbers in square 
brackets represent the known subset of blaKPC plasmids in each cell. Exact test compares presence/absence of 
each Inc type by ST. The replicon type specifically associated with blaKPC could not be evaluated in 15 isolates, 
due to limitations of the assemblies. aone multi-replicon plasmid also containing IncFIA. bone multi-replicon 
plasmid also containing IncFIA and IncR. cone multi-replicon plasmid also containing IncFIB. done multi-
replicon plasmid also containing repA.
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(all n = 1). Four (14%) blaKPC plasmids were multi-replicon constructs, namely: col/repA, FIB/FII, FIA/FII, and 
FIA/FII/R.
Common IncN plasmid backbones have dispersed globally within E. coli. From GenBank, we 
selected all unique, fully sequenced IncN-blaKPC plasmid sequences (Table S4) for comparison, dating from as 
early as 2005, around the time of the earliest reports of KPC-producing E. coli. The plasmid backbones and 
flanking sequences surrounding blaKPC in these 16 plasmid references and a subset of 12 study sequences (see 
“Methods”) were consistent with multiple acquisitions of two known IncN-Tn4401-blaKPC complexes in divergent 
E. coli STs: firstly, within a Plasmid-9 (FJ223607, 2005, USA)-like background, and secondly, within a Tn2/3-like 
element in a Plasmid-12 (FJ223605, 2005, USA)-like background.
In the first instance, genetic similarities were identified between Plasmid-9, pKPC-FCF/3SP, pKPC-FCF13/05, 
pCF8698, pKP1433 (representing a hybrid IncN), and blaKPC plasmids from isolates ecol_516, ecol_517, ecol_656, 
and ecol_736 (this study). Plasmid-9 contains duplicate Tn4401b elements in reverse orientation with four differ-
ent 5 bp flanking sequences in an atypical arrangement within a group II intron35. The backbone structures of the 
other plasmids in this group are consistent with a separate acquisition event of a Tn4401b element between the pld 
and traG regions within an ancestral version of the Plasmid-9 structure, with the generation of a flanking TTCAG 
target site duplication (TSD) (labelled as Plasmid 9-like plasmid (hypothetical), Fig. 2). International spread 
followed by local evolution both within and across species would account for the differences between plasmids, 
including: (i) nucleotide level variation (observed in all plasmids); (ii) small insertion/deletion events (observed 
in all plasmids); (iii) larger insertion/deletion events mediated by transposable elements (e.g. pCF8698_KPC_2); 
and (iv) likely homologous recombination, resulting in clustered variation within a similar plasmid backbone 
(e.g. ecol_656/ecol_736), as well as more distinct rearrangements, including the formation of “hybrid” plasmids 
(e.g. pKP1433)(Fig. 2).
In Plasmid-12 (FJ223605), Tn4401b has inserted into a hybrid Tn2-Tn3-like element (with associated drug 
resistance genes including blaTEM-1, blaOXA-9, and several aminoglycoside resistance genes), albeit in the absence 
of target sequence duplication, possibly as the result of an intra-molecular, replicative transposition event gen-
erating mismatched target site sequences (L TSS = TATTA; R TSS = GTTCT). This complex is in turn located 
Figure 1. Phylogeny of KPC-Escherichia coli identified from global carbapenem resistance surveillance 
schemes, 2008–2013. Panels to the right of the phylogeny represent common resistance gene mechanisms 
(full details of resistance gene typing in Table S2), core and accessory genome components. For the accessory 
genome panel, blue represents annotated regions that are present, and white those that are absent.
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between two IS15DIV (IS15Δ)/IS26-like elements flanked by 8 bp inverted repeats, and located between the 
traI (891 bp from 3′ end) and pld loci (~28 Kb; Fig. 3A). The backbone components of the IncN Plasmid-12 are 
consistent with those seen in an NIH outbreak5 and in a rearranged version in a University of Virginia outbreak 
(CAV1043; 2008)6. From this study, plasmids from ecol_224, ecol_881, ecol_AZ159, ecol_422, and scaffolds from 
ecol_AZ151, ecol_744, ecol_AZ150 all share near identical structures to Plasmid-12, with clustered nucleotide 
level variation present in the traJ-traI genes, consistent with a homologous recombination event affecting this 
region, and evidence of sporadic insertion/deletion events (Fig. 3A). However, the blaKPC-Tn4401 structures in 
these isolates are almost entirely degraded by the presence of other mobile genetic elements (MGEs), including 
Tn2/Tn3-like elements, ISKpn8/27 and Tn1721. In ecol_224, blaKPC-2 has been inserted into the IncN backbone as 
part of two repeat, inverted Tn3-like structures, flanked by a TTGCT TSD, and closer to traI (136 bp from 3′ end) 
than the aforementioned IS15DIV (IS15Δ)/IS26-like complex in Plasmid-12 (Fig. 3B). Although it is not possible 
to accurately trace the evolutionary history of this genomic region given the available data, the presence of shared 
signatures of this structure in ecol_422, ecol_744, ecol_881, ecol_AZ159, ecol_AZ150 and ecol_AZ151 suggest a 
common acquisition, and multiple subsequent rearrangements mediated by the presence of the large number of 
MGEs flanking blaKPC-2.
Col-like plasmids may represent an important vector of transmission for blaKPC in E. coli. Small 
col-like plasmids were the second most common type of plasmid carrying blaKPC in E. coli (n = 5 [plasmids with 
single replicons only]), but three of these were identical (blaKPC-2, 16,559 bp), all isolated in Pittsburgh, USA, from 
ST131 isolates across a two year timeframe (ecol_276 [PacBio; 2010], ecol_356 [2011], ecol_875 [2013]). These 
three isolates additionally contained FIA, FIB, FII, X3 and X4 replicons, suggesting stable persistence of a clonal 
strain + plasmids over time, consistent with both SNV/core and accessory genome analyses (Fig. 1, Figure S1).
The other two col-like plasmids effectively represent short stretches of DNA encoding different mobiliza-
tion genes (mbeA/mbeC/mbeD) harnessed to Tn4401/blaKPC modules. The 5 bp sequences flanking Tn4401 
Figure 2. Comparison schematic of FJ223607-like (Plasmid 9-like) IncN plasmids (publicly available; this 
study), and their geographic origin/dates of isolation. Plasmid sequence names in red are those from this 
study, derived from PacBio data and closed (ecol_517, ecol_656) or incomplete plasmid structures (ecol_516, 
ecol_736) derived from Illumina data. Aligned bars adjacent to plasmid names represent plasmid sequences: 
light grey denotes regions with 100% sequence identity; black represents nucleotide diversity between 
sequences; and thin lines represent indels. Coding sequences are represented by fat arrows below individual 
sequence bars and are colour-coded as per the colour key. The inset schematic describing genetic variation 
between sequences depicts examples of evolutionary events identified: (a) single nucleotide level change, (b) 
small indels (≤100 bp), (c) large indels (>100 bp), (d) recombination events.
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Figure 3. Comparison schematic of FJ223605-like (Plasmid-12-like) IncN KPC plasmids from this study. Panel 
3A. Geographic origin, dates of isolation and overall alignment of plasmid/contig structures. Plasmid sequence 
names in red are those from this study, derived from PacBio data and closed (ecol_224, ecol_422, ecol_881, 
ecol_AZ159) or incomplete plasmid structures (ecol_744, ecol_AZ151, ecol_AZ150) derived from Illumina 
data. Aligned bars adjacent to plasmid names represent plasmid sequences: light grey denotes regions with 
100% sequence homology; black represents nucleotide diversity between sequences; and thin lines represent 
indels. Coding sequences are represented by fat arrows below individual sequence bars and are colour-coded 
as per the colour key. The inset schematic describing genetic variation between sequences depicts examples of 
evolutionary events identified: (a) single nucleotide level change, (b) small indels (≤100 bp), (c) large indels 
(>100 bp), (d) recombination events. Panel 3B. Close-up of the region between traI and pld containing blaKPC-2 
in study isolates only. Coding sequences are colour-coded as in Fig. 3A; sequence regions referred to in the text 
are annotated.
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were consistent with direct, intermolecular transposition in both cases (ecol_870: TGTTT-TGTTT; ecol_867: 
TGTGA-TGTGA). A col/repA co-integrate plasmid was also observed in this dataset (ecol_AZ161), in which 
Tn4401b was inserted between colE3 signature sequences and a Tn3 element (Tn4401 TSS: AGATA-GTTCT). The 
formation of such co-integrate plasmid structures in E. coli has also been previously described36, including that of 
a fused col/pKpQIL-like plasmid structure (pKpQIL being historically associated with blaKPC)37.
Col-like plasmids have been associated with KPC-producers in other smaller, regional studies21, 38. Of con-
cern, these small vectors have been shown to be responsible for the inter-species diffusion of qnr genes mediating 
fluoroquinolone resistance, even in the absence of any obvious antimicrobial selection pressure39. The significant 
association of col-like plasmids with particular E. coli STs (predominantly ST131) in this study could be one 
explanation for the disproportionate representation of blaKPC in this lineage.
Diverse Tn4401 5 bp target site sequences (TSSs) support high transposon mobility. Complete 
Tn4401 isoforms flanking blaKPC-2 or blaKPC-3 were observed in only 24/43 (56%) isolates, including Tn4401a/a-like 
(n = 10; one isolate with a contig break upstream of blaKPC), Tn4401b (n = 12), and Tn4401d (n = 2) variants. 
Eleven different 5 bp target site sequence (TSS) pairs were identified, of which 7 (64%) were not observed in any 
comparison plasmid downloaded from GenBank (Table S5). Tn4401a had three different 5 bp TSSs, Tn4401b 
seven, and Tn4401d one. Most represented TSDs, but in three cases different 5 bp TSSs were flanking Tn4401, 
consistent with both direct inter- and replicative intra-molecular transposition events.
From the full set of GenBank plasmids and in vitro transposition experiments carried out by others, 30 dif-
ferent types of 5 bp TSS pairs have been characterized, seven in the experimental setting only40. The downloaded 
plasmids come from a range of species and time-points (2005–2014), although they may under-represent wider 
Tn4401 insertion site diversity as a result of sampling biases. Our data however would be consistent with signif-
icant Tn4401 mobility within E. coli following acquisition of diverse Tn4401 isoforms and/or represent multiple 
importation events into E. coli from other species.
The traditional association of blaKPC with Tn4401 has been significantly eroded in KPC plas-
mids in E. coli. Notably, in the other 19/43 (44%) isolates the Tn4401 structure had been degraded through 
replacement with MGEs, only some of which have been previously described41, 42. Two isolates had novel 
Tn4401Δb structures (upstream truncations by IS26 [ecol_270] or IS26-ΔIS5075 [ecol_584]). A Tn4401e-like 
structure (255 bp deletion upstream of blaKPC) was present in three isolates (ecol_227, ecol_316, ecol_583): 
this was further characterized in one complete PacBio plasmid assembly (ecol_316) and represented a rear-
rangement at the site of the L TSS of the ISKpn7 element. In this plasmid, a second, partial Tn4401 element 
was present without blaKPC, which would be consistent with an incomplete, replicative, intra-molecular trans-
position event (GGGAA = L TSS and R TSS on the two Tn4401b elements, in reverse orientation). Other 
motifs flanking blaKPC included: hybrid Tn2/Tn3 elements-ISKpn8/27-blaKPC (n = 1; ecol_224); IS26-ΔtnpR(T
n3)-ISKpn8/27- blaKPC-ΔTn1721-IS26 (n = 5; ecol_AZ153-AZ155, ecol_AZ166, ecol_AZ167); ISApu2-tnpR(T
n3)-ΔblaTEM -blaKPC- korC-klcA-ΔTn1721-IS26 (n = 1; ecol_542); IS26-tnpR(Tn3)-ΔblaTEM -blaKPC-korC-IS26 
(n = 1; ecol_545); hybrid Tn2/Tn3 elements + ΔblaTEM-blaKPC-ΔTn1721 (n = 2; ecol_744, ecol_422), Tn3 
elements-ΔblaTEM-blaKPC- ΔTn1721 (n = 4; ecol_881, ecol_AZ151, ecol_AZ159, ecol_AZ150) and ΔTn3-Δ 
-ΔIS3000 (Tn3-like) (n = 1; ecol_AZ152). We were unable to assess the flanking context of blaKPC in ecol_452 
due to limitations of the assembly.
This apparent diversity in independently acquired MGEs around the blaKPC gene extends the means by which 
blaKPC can be mobilized. Interestingly, as observed previously43, all the degraded Tn4401 sequences in this dataset 
were associated with variable stretches of flanking Tn2/3-like sequences, suggesting that the insertion of Tn4401 
into a Tn2/Tn3-like context may have enabled the latter to act as a hotspot for the insertion of other MGEs6. A 
particular finding of note is the association with IS26, which has been linked to the dissemination of several other 
resistance genes in E. coli, including CTX-M ESBLs24, 44; is able to increase the expression of closely co-located 
resistance genes45; participates in co-integrate formation and hence plasmid rearrangement46; and enhances the 
occurrence of other IS26-mediated transfer events into plasmids harbouring IS2646.
Discussion
This study of KPC-E. coli obtained from two global resistance surveillance schemes has demonstrated the diver-
sity of genetic structures associated with blaKPC at all genetic levels, including: (i) host bacterial strain; (ii) plas-
mid types; (iii) associated transposable MGEs, including transposons and insertion sequences; and (iv) blaKPC 
alleles. This has previously been observed within institutional, poly-species outbreaks, particularly for non-E. 
coli Enterobacteriaceae5, 6, as well as in a more recent study of nine KPC-E. coli from the US47. We have iden-
tified global and regional blaKPC spread at the strain and plasmid levels, including signatures consistent with 
inter-species spread of plasmids, over short timeframes. Although the geographic reach of sampling has been 
more substantial than any other similar study, there are some limitations in the sampling consistency of both 
surveillance schemes22 (e.g. isolates from China were only submitted in 2008, 2012 and 2013).
We utilized long-read sequencing on only a subset of isolates, given resource limitations, allowing us to 
completely resolve chromosomal and plasmid structures in less than half the isolates. Nevertheless, despite this 
drawback, we have highlighted the extraordinary diversity present. This study, along with other recent analyses 
utilizing long-read sequencing to resolve antimicrobial resistance plasmids5, 6, also demonstrates the difficulty in 
making evolutionary comparisons for MGEs, given the absence of effective phylogenetic methods/tools to char-
acterize their genetic histories which commonly involve genetic rearrangements, and evolutionary events that are 
not restricted to single nucleotide mutations.
This study has demonstrated the particular association of blaKPC in E. coli with IncN plasmids, previously 
associated with the spread of other antimicrobial resistance elements48, as well as col-like plasmids, which are 
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small, potentially highly mobile, and generally high copy-number units. The traditional association of blaKPC 
with Tn4401 has apparently been eroded in E. coli, with the complete Tn4401 structure absent in 50% of strains 
investigated. This finding is in contrast to most global descriptions of K. pneumoniae where blaKPC has been stably 
associated with largely intact Tn4401 isoforms for more than a decade. Instead, other shorter MGEs, such as Tn2/
Tn3-like elements and IS26, appear to be commonly involved in blaKPC dispersal in E. coli. These MGEs have been 
associated with the spread of multiple resistance mechanisms, such as blaTEM and blaCTX-M, and will potentially 
similarly contribute to the dissemination of blaKPC in E. coli. We did not undertake any functional assays inves-
tigating the dynamics of blaKPC transmission in E. coli to support this hypothesis, but this would be illuminating 
work for future study.
The global emergence and spread of blaKPC in E. coli has been driven by multiple mechanisms, including local 
and international spread of highly genetically related strains, exchange of plasmids with other Enterobacteriaceae 
and between E. coli lineages, transposition events within the species, and a breakdown of the traditional associ-
ation of blaKPC with Tn4401. The genetic flexibility observed is impressive, especially given the timeframes and 
number of KPC-E. coli characterized. Tracking the spread of resistance genes given such multi-level genetic var-
iability is complicated, even with a high-resolution typing method such as WGS. The association of E. coli, both 
a common pathogen and commensal in a wide range of environmental/animal reservoirs, with MGEs (col-like 
plasmids, IS26) that have been shown to facilitate the dissemination of other successful resistance genes even in 
the absence of antimicrobial selection pressures, may represent a difficult situation to control.
Methods
Isolate collection and sampling frames. Isolates were obtained from two global antimicrobial resistance 
surveillance schemes (The Merck Study for Monitoring Antimicrobial Resistance Trends [SMART], 2008–2012; 
AstraZeneca global surveillance study of antimicrobial resistance, 2012–2013; 417 institutions operating in 95 
countries), as previously described22. Of 55,874 isolates collected, 45 (0.08%) were positive for blaKPC by PCR 
(n = 7 from 2010, 10 from 2011, 13 from 2012, 15 from 2013; Table S1). Isolates had been previously character-
ized using partial, sequenced-based typing methods, including multi-locus sequence typing (MLST; Achtman 
scheme), fimH typing, PCR for beta-lactamases, strain/plasmid PFGE (Table S1)22.
DNA extraction and sequencing. All isolates were sequenced on the Illumina MiSeq; a subset of 18 were 
purposively selected for PacBio sequencing, to capture potential diversity across a range of years of isolation, 
geographic location, standard ST, plasmid size and resistance gene content (based on laboratory typing). DNA 
for sequencing was extracted from sub-cultures of bacterial stocks (frozen at −80 °C; cultured overnight on 
Columbia blood agar at 37 °C) using the Qiagen Genomic tip 100/G extraction kit, as per the manufacturer’s 
instructions (Qiagen, Hilden, Germany; catalogue no: 10243).
DNA libraries for MiSeq sequencing were generated and normalized using 300 base, paired-end Nextera XT 
DNA library preparation kits (Illumina, San Diego, CA, USA). PacBio sequencing on the subset of strains was 
performed as previously described49; in these cases, the same DNA extract was used for both Illumina and PacBio 
sequencing approaches.
Sequence data processing. Illumina (short-read data). Mapping-based approaches: Prior to 
reference-based mapping to the O150:H5 SE15 E. coli reference genome (Genbank accession: NC_013654), 
Illumina data were trimmed using cutadapt version 1.5. SE15, which is ST131, was chosen as the reference given 
the largest number of strains sequenced (and in the dataset) came from this ST. Repetitive regions of the reference 
were identified using self-self BLASTn analysis with default settings; these regions were then masked prior to 
mapping and base calling. Properly paired sequence reads were mapped to the reference using Stampy (v1.0.17) 
(Supplementary methods).
Single-nucleotide variants (SNVs) were determined across all mapped non-repetitive sites using SAMtools 
(version 0.1.18) mpileup. mpileup was run twice to separate high-quality base calls from low-quality base calls; 
variant call format (VCF) files of annotated variant sites were created using GATK (v1.4.21). Base calls derived 
from these two VCF files were filtered to retain only high quality calls (Supplementary methods).
Core variable sites (site called in all sequenced isolates, excluding “N” or “-” calls) derived from mapping to 
the SE15 reference were “padded” with invariant sites in a proportion consistent with the GC content and length 
of the reference genome (4.72 Mb, 51% average GC content), to generate a modified alignment of input sequences 
to generate phylogenies. Phylogenies were reconstructed using RaxML (Version 7.7.6)50, with a generalized time 
reversible model, four gamma categories (allowing for variable rates of mutation between sites), and bootstrapped 
100 times.
De novo assemblies of Illumina data: De novo assemblies of short-read Illumina data for all isolates were gen-
erated using the A5-MiSeq pipeline (version 20140604; default settings)51, which includes adapter/low-quality 
region read trimming steps (Trimmomatic), initial contig assembly, crude scaffolding, misassembly correction 
and final scaffolding. We used the unscaffolded contigs file in subsequent analyses (*.contigs.fasta).
PacBio (long-read data). DNA library preparation for and sequencing on the PacBio RSII were performed 
in accordance with the manufacturer’s instructions, using P5-C3 sequencing enzyme and chemistries respectively, 
and following a 7–50 kbp fragment selection step (full details in ref. 49). De novo assemblies were constructed 
using HGAP3 (version 2.2.0)52, resulting in phased chromosomal and plasmid contigs, which were manually 
closed by resolving and trimming overlapping repeats at the contig ends. Illumina reads for the respective isolate 
were then mapped to the resulting closed PacBio assemblies using bwa-MEM (version 0.7.9a-r786, default set-
tings)53. Read pileups were visualized in Geneious54; mismatches between the sequence derived from mapping 
and the reference PacBio assemblies were inspected manually to identify the correct structure. Finally, to capture 
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small plasmids that may have been filtered out due to size-selection of DNA fragments >7 kbp prior to PacBio 
sequencing, unmapped Illumina reads (extracted using the SAMtools view command, with the -f 12 flag) derived 
from this process were de novo assembled using the A5-MiSeq pipeline 2014060451; any assembled contigs were 
manually closed by assessing for and trimming overlapping repeats (100% match over a length of ≥100 bp; no 
match to any other contig in the assembly). The final consensus chromosomal and plasmid sequences derived 
from these processes were used in analyses and submitted to GenBank.
Automated and manual annotation of de novo assemblies. All plasmid structures and de novo 
assemblies were annotated using PROKKA55, with subsequent manual refinement of annotations for regions of 
interest using BLASTn56 and the NCBI bacterial and ISFinder databases57. Alignments of sequence structures 
were visualized and modified in Geneious. blaKPC-containing contigs identified in the de novo assemblies derived 
from Illumina data were manually inspected for overlapping repeats as above; if these were present, these contigs 
were considered additional putative KPC plasmids and trimmed and closed as above.
Core/accessory genome comparisons. These were undertaken using the pangenome pipeline, ROARY27, 
by inputting the *.gff files generated from the PROKKA annotation of each of the Illumina de novo assemblies 
(default settings). Comparisons were made separately for all isolates and the ST131 subset. The output gene_pres-
ence_absence.csv files were processed using the pheatmap function in R. Resistance genes were identified using 
ResistType, a command-line tool developed in-house that identifies the presence of reference loci in WGS data 
using both BLASTn against de novo assemblies and mapping-based approaches, and estimates copy number by 
comparing contig coverage at any given locus with median contig coverage [scripts, reference resistance gene 
database and manual available at: https://github.com/hangphan/resistType]. These features were plotted on the 
maximum likelihood phylogenies using the Ape package in R.
Comparisons with publicly available KPC plasmid sequences. All complete KPC RefSeq plasmid 
sequences available in GenBank in May 2015 were identified using the search terms “plasmid” + “KPC” + “com-
plete sequence”. The resulting list was filtered manually to exclude any additional sequences present that were not 
complete plasmid sequences. In total 63 plasmid sequences were included (Table S5).
For the IncN plasmid comparisons, we included the following from our dataset: (i) six cases where PacBio 
sequencing had fully resolved the blaKPC IncN plasmid (ecol_224, ecol_422, ecol_517, ecol_656, ecol_881, ecol_
AZ159); (ii) two cases where the IncN rep and blaKPC were co-located on the same, incomplete contig (ecol_516, 
ecol_736); and (iii) three cases where blaKPC was present in isolates containing an IncN rep and on contigs that 
showed high similarity to the IncN plasmid backbones under scrutiny (ecol_744, ecol_AZ150, ecol_AZ151).
Availability of Data and Materials. Sequencing datasets (Illumina raw reads, PacBio assemblies) 
are available in GenBank/SRA (project accession: PRJNA316786 (https://www.ncbi.nlm.nih.gov/biopro-
ject/?term=316786)(Table S1).
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